Renovia Inc’s Chief Executive Officer, Marc Beer, has some big plans for the future of the pharmaceutical company. Their latest round of fundraising gave Marc Beer’s Renovia around $42 million to work with, this includes $10 million of debt. With a focus on the disorders associated with pelvic floor disorder, women everywhere will soon see big changes to how their disorder is treated.
The products that Marc Beer and Renovia are using these funds to develop include products that will be used for both therapeutic and diagnostic purposes. It is estimated that 250 million women around the world suffer from these disorders that can include symptoms like discomfort, pain, and urinary incontinence. Renovia Inc. has already had one of their products approved for use in the United States in April.
One of the earliest investors in Renovia, The Longwood Fund, is putting their faith behind Marc Beer and his company once again for the 2nd round of funding. The funding for Renovia was put together and led by Perceptive Advisors of New York and Ascension Ventures of Missouri. Marc Beer is satisfied and excited about the funds that were raised for the products in development.
Currently, there are 4 different products that Renovia is in testing in development stages with. One of these products is a new version of their device that was approved by the FDA. With the help of these funds, Marc Beer hopes that their plans will be able to be brought to market soon.
Marc Beer is excited to have The Longwood Fund back on board with their company during this round. The investors that have put their faith into Renovia share the same vision as Marc Beer. They want to be able to treat and diagnose these problems that plague so many women in more effective ways.
Their new products will include a digital platform that will allow customers access to the newest treatment options available as well as information about their condition. In addition, Marc Beer believes that the sensor technology used by the Renovia exclusively will have a huge impact on pelvic floor disorders. Over time, the cost to treat pelvic floor disorder is expected to go down and a better understanding will be gained of the medical issue.
Marc Beer has a decade and a half of experience in the financial side of the medical industry. He has worked with pharmaceuticals, diagnostics, devices, and biotechnology. Renovia was founded by Marc Beer in 2016 with Yolanda Lorie and Ramon Iglesias. Marc Beer graduated from Miami University in Ohio with a Bachelors degree and is part of the school’s Business Advisory Council. Learn more : https://renoviainc.com/leadership/